Concert Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-5,283
| Closed | -$392K | – | 432 |
|
|
2017
Q1 | $392K | Sell |
5,283
-108
| -2% | -$8.01K | 0.09% | 302 |
|
|
2016
Q4 | $400K | Sell |
5,391
-2,673
| -33% | -$198K | 0.09% | 302 |
|
|
2016
Q3 | $702K | Sell |
8,064
-57
| -0.7% | -$4.96K | 0.09% | 297 |
|
|
2016
Q2 | $699K | Buy |
8,121
+589
| +8% | +$50.7K | 0.09% | 268 |
|
|
2016
Q1 | $602K | Sell |
7,532
-138
| -2% | -$11K | 0.08% | 306 |
|
|
2015
Q4 | $966K | Buy |
7,670
+21
| +0.3% | +$2.65K | 0.13% | 201 |
|
|
2015
Q3 | $794K | Sell |
7,649
-125
| -2% | -$13K | 0.11% | 246 |
|
|
2015
Q2 | $960K | Sell |
7,774
-400
| -5% | -$49.4K | 0.12% | 214 |
|
|
2015
Q1 | $530K | Sell |
8,174
-1,116
| -12% | -$72.4K | 0.15% | 190 |
|
|
2014
Q4 | $1.11M | Buy |
9,290
+239
| +3% | +$28.6K | 0.17% | 156 |
|
|
2014
Q3 | $1.01M | Sell |
9,051
-35
| -0.4% | -$3.91K | 0.14% | 129 |
|
|
2014
Q2 | $831K | Sell |
9,086
-127
| -1% | -$11.6K | 0.1% | 172 |
|
|
2014
Q1 | $630K | Sell |
9,213
-4,200
| -31% | -$287K | 0.08% | 226 |
|
|
2013
Q4 | $988K | Buy |
13,413
+1,410
| +12% | +$104K | 0.13% | 136 |
|
|
2013
Q3 | $919K | Buy |
12,003
+600
| +5% | +$45.9K | 0.13% | 128 |
|
|
2013
Q2 | $912K | Buy |
+11,403
| New | +$912K | 0.14% | 116 |
|